- KR-33493
-
- $34.00
-
2026-05-11
- CAS:1021497-97-1
- Purity: 99.96%
- Supply Ability: 10g
- KR-33494
-
-
2025-12-25
- CAS:1021497-97-1
- Min. Order: 1gram
- Purity: 99%
- Supply Ability: 10kg
- KR-33494
-
- $100.00
-
2022-02-25
- CAS:1021497-97-1
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 100KG
|
| | KR-33494 Basic information |
| Product Name: | KR-33494 | | Synonyms: | KR-33494;4-(2-(4-bromophenylthio)acetamido)-1-phenethyl-1H-pyrazole-3-carboxylic acid;KR-33493;4-[2-(4-bromo-phenylsulfanyl)-acetylamino]-1-phenethyl-1H-pyrazole-3-carboxylic acid;CS-2472;KR33494;KR 33494;1H-Pyrazole-3-carboxylic acid, 4-[[2-[(4-bromophenyl)thio]acetyl]amino]-1-(2-phenylethyl)-;4-[[2-[(4-Bromophenyl)thio]acetyl]amino]-1-(2-phenylethyl)-1H-pyrazole-3-carboxylic acid | | CAS: | 1021497-97-1 | | MF: | C20H18BrN3O3S | | MW: | 460.34 | | EINECS: | | | Product Categories: | | | Mol File: | 1021497-97-1.mol |  |
| | KR-33494 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO:61.5(Max Conc. mg/mL);133.6(Max Conc. mM) | | form | A crystalline solid | | color | White to off-white |
| | KR-33494 Usage And Synthesis |
| Uses | KR-33493 is a potent inhibitor of Fas-mediated cell death (FAF1). | | in vivo | Body weight changes of both sexes are not related to KR-33493 in all doses. In rats administrated KR-33493 for 4 weeks, no test article-related changes in any treated groups of either sex are found in hematology, serum biochemistry, and urinalysis. In dogs administrated KR-33493 for 2 weeks, red blood cell count (RBC) value in males is significantly higher at the 1000 mg/kg/day dose than that of the control group (i.e., 6.96±0.323 vs. 6.12±0.418). However, the change of RBC is recovered after the end of the administration period. The dose-normalized AUClast is not significantly different between the groups, suggesting that KR-33493 is governed by linear kinetics[1]. | | IC 50 | Fas | | References | [1] Jeong JW, et al. Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-parkinson's disease agent, after oral administration in rats and dogs. Regul Toxicol Pharmacol. 2016 Nov;81:387-396. DOI:10.1016/j.yrtph.2016.09.022 |
| | KR-33494 Preparation Products And Raw materials |
|